Stanford Brain Metastases Consortium
The Stanford Brain Metastases Consortium is a unique partnership between scientists, physicians and surgeons from across the Stanford community, that brings together experts in research and clinical care of brain metastases. Through more focused and collaborative efforts, our goal is to increase the number of available clinical trials and collaborative publications, and to enhance our patients' experience through a team-based approach to care.
The Brain Metastases Consortium facilitates collaborative research between the many exceptional researchers and clinicians at Stanford University. These projects involve specialists from different departments, whose synergistic talents and interests when combined, exponentially advance our understanding of, and capacity to treat, metastatic brain tumors. Interests include cancer biology, radiation oncology, neuroscience, immunology, medical oncology, neurosurgery, physics, bio-engineering, neuro oncology, and population science, among others.
Featured Clinical Trial:
Video: New Technology Can Make Brain Surgery Safer
Lung Cancer Patient Finds Health Again at Stanford
Eight years after being diagnosed with stage-4 lung cancer, whose treatment led to other health complications - including six brain tumors - Ginger Powell is now cancer-free.
"We're taking a multidisciplinary, collaborative, and driven approach to improving outcomes for patients with brain metastases."
- Melanie Hayden Gephart, MD
Associate Professor, Department of Neurosurgery
Director, Stanford Brain Metastases Consortium
Brain Tumor Support Group
Come share your story, get important medical updates, and learn about coping with symptoms and psychological changes. This group is for patients and families. Walk-ins welcome.
Research Speed-Dating Symposium
Thursday, September 6, 2018
4:00PM - 5:30PM
Beckman Center, Room B302
Bringing our experts together to collaborate on research goals, all Consortium faculty encouraged to attend. Please RSVP by filling out this Survey prior to attending.
Consortium Kick-off Meeting
Feburary 2, 2018
Stanford Cancer Center
The introductory Brain Metastasis Consortium meeting will bring together Stanford experts to kick-off the Consortium and plan for upcoming activities.